COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...
SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...
20 U.S. states (plus D.C.) had "very high" levels of SARS-CoV-2—the virus that causes COVID-19—present in wastewater for the week between December 29, 2024 and January 04, 2025. This is a jump ...
An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...
New data from the U.S. Centers for Disease Control and Prevention (CDC) revealed which U.S. states had "very high" levels of SARS-CoV-2—the virus that causes COVID-19—present in wastewater ...
In sum, the findings illustrate fluoxetine's weak antiviral activity in adults with early symptomatic COVID-19. There were no significant differences in the time to symptom or fever resolution ...